PIFotal E-learning

E-learning based on the PIFotal study

Between Oct. 2020 and May 2021, GPRI conducted a large international real-world-evidence study called PIFotal, in which more than 1,400 people participated. This study focussed on the inhalation strength, inhalation technique and adherence of patients with COPD using dry powder inhalers.

The PIFotal study showed that sub-optimal peak inspiratory flow (PIF) compared to optimal PIF was associated with lower health status in patients with COPD. In addition, 13% of patients were found to be unable to inhale forcefully enough with their prescribed dry powder inhaler.

The results of the PIFotal study have been published and can be found here:

https://pubmed.ncbi.nlm.nih.gov/35618739/W H Kocks, Janwillem et al. “Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.” NPJ primary care respiratory medicine vol. 32,1 18. 26 May. 2022

https://pubmed.ncbi.nlm.nih.gov/36575175/ Leving, Marika T et al. “Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.” NPJ primary care respiratory medicine vol. 32,1 59. 27 Dec. 2022

https://pubmed.ncbi.nlm.nih.gov/36185173/ Leving, Marika T et al. “Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.” International journal of chronic obstructive pulmonary disease vol. 17 2401-2415. 25 Sep. 2022

Based on the PIFotal study, GPRI has developed an E-learning focused on finding a suitable inhaler for patients with COPD.

The E-learning is free of charge and the slides and spoken text are in English. Is is accredited with 1 point through the NVALT, ABC1, and the de NvvPO. Europe wide is it accredited at the EACCME (European Accreditation Council for Continuing Medical Education)and includes the following countries: